Related references
Note: Only part of the references are listed.Tau-positron emission tomography correlates with neuropathology findings
Val J. Lowe et al.
ALZHEIMERS & DEMENTIA (2020)
Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age
Tobey J. Betthauser et al.
BRAIN (2020)
In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand F-18-MK-6240 in Humans from Alzheimer Disease Dementia to Young Controls
Tobey J. Betthauser et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Cortical thickness atrophy in the transentorhinal cortex in mild cognitive impairment
Sue Kulason et al.
NEUROIMAGE-CLINICAL (2019)
Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer's disease
Tharick A. Pascoal et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions
Victor L. Villemagne et al.
NATURE REVIEWS NEUROLOGY (2018)
Imaging the evolution and pathophysiology of Alzheimer disease
William Jagust
NATURE REVIEWS NEUROSCIENCE (2018)
In vivo quantification of neurofibrillary tangles with [18F]MK-6240
Tharick A. Pascoal et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders
Rik Ossenkoppele et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia
Val J. Lowe et al.
BRAIN (2018)
Fluorescence and Autoradiographic Evaluation of Tau PET Ligand PBB3 to α-Synuclein Pathology
Shunsuke Koga et al.
MOVEMENT DISORDERS (2017)
Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain
Kok Pin Ng et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Tau Positron Emission Tomographic Imaging in Aging and Early Alzheimer Disease
Keith A. Johnson et al.
ANNALS OF NEUROLOGY (2016)
Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages
Adam J. Schwarz et al.
BRAIN (2016)
The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging
Brian A. Gordon et al.
BRAIN (2016)
Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
Serge Gauthier et al.
LANCET (2016)
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Clifford R. Jack et al.
NEUROLOGY (2016)
PET Imaging of Tau Deposition in the Aging Human Brain
Michael Schoell et al.
NEURON (2016)
VoxelStats: A MATLAB Package for Multi-Modal Voxel-Wise Brain Image Analysis
Sulantha Mathotaarachchi et al.
FRONTIERS IN NEUROINFORMATICS (2016)
[18F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease
Ryuichi Harada et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
PET Quantification of Tau Pathology in Human Brain with 11C-PBB3
Yasuyuki Kimura et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Primary age-related tauopathy (PART): a common pathology associated with human aging
John F. Crary et al.
ACTA NEUROPATHOLOGICA (2014)
Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807
David T. Chien et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls
Masahiro Maruyama et al.
NEURON (2013)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach
Thomas J. Montine et al.
ACTA NEUROPATHOLOGICA (2012)
Clinical Validation of 18F-AZD4694, an Amyloid-β-Specific PET Radioligand
Zsolt Cselenyi et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
101 labeled brain images and a consistent human cortical labeling protocol
Arno Klein et al.
FRONTIERS IN NEUROSCIENCE (2012)
The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships
Julie S. Snowden et al.
BRAIN (2011)
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Heiko Braak et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study
Melissa E. Murray et al.
LANCET NEUROLOGY (2011)
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2006)
Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment
AL Guillozet et al.
ARCHIVES OF NEUROLOGY (2003)
Untangling tau-related dementia
P Heutink
HUMAN MOLECULAR GENETICS (2000)
Share Paper
